MedPath

ASTRA STUDY (Angioplasty, Stent X-ray Intensive Antithrombotic Therapy) A PHASE III, PROSPECTIVE AND RANDOMIZED, MULTICENTER STUDY, OPEN LABEL, PARALLEL-GROUP, BLINDED ADJUDICATION, TO INVESTIGATE THE EFFECTIVENESS Of BRACHYTHERAPY IN THE REDUCTION OF RESTENOSIS AFTER FEMURAL AND POPLITEAL ARTERIES ANGIOPLASTY WITH OR WITHOUT SELECTIVE STENTING AND/OR INTENSIVE ANTITHROMBOTIC THERAPY IN PATIENTS WITH PERIPHERAL ORGANIC ARTHERY DISEASE OF THE INFERIOR LIMBS (FONTAINE-LERICHE STAGE IIb-IV)

Conditions
PAOD (Fontaine-Leriche St. IIb-IV)requiring percutaneous angioplasty with or without stenting
MedDRA version: 6.1Level: PTClassification code 10016426
Registration Number
EUCTR2005-002251-41-IT
Lead Sponsor
AZIENDA OSPEDALIERA ARCISPEDALE S. MARIA NUOVA
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Recruiting
Sex
All
Target Recruitment
320
Inclusion Criteria

Are the trial subjects under 18? no
Number of subjects for this age range:
F.1.2 Adults (18-64 years) yes
F.1.2.1 Number of subjects for this age range
F.1.3 Elderly (>=65 years) yes
F.1.3.1 Number of subjects for this age range

Exclusion Criteria

Not provided

Study & Design

Study Type
Interventional clinical trial of medicinal product
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath